Search results
Why Blue Cross of Michigan is axing coverage of popular weight loss drugs
Detroit News· 2 days agoBlue Cross Blue Shield of Michigan is dropping coverage of popular weight loss drugs, citing...
Biophytis Announces Filing of an IND Application with the US FDA for its Phase 2 Study in Obesity
Digital Journal· 5 days agoFood and Drug Administration (FDA) regarding its phase 2 OBA clinical study in obesity with BIO101 ...
Weight Loss Drugs Like Wegovy and Ozempic May Change Sense of Taste
Prevention· 1 day agoGLP-1 medications, like Ozempic and Wegovy, may change the sense of taste in people with obesity, a...
Experimental GLP-1 med may be breakthrough against fatty liver disease
Medical Xpress· 5 days agoThe drug under development, survodutide, helped up to 83% of patients gain real improvements in...
Is Eli Lilly Stock A Buy After FDA Advisors Back Its Alzheimer's Drug?
Investor's Business Daily· 3 days agoMost of the time ARIA is temporary and asymptomatic. But the Food and Drug Administration's advisors...
Lilly Alzheimer’s drug gets unanimous backing of FDA panel
BioPharma Dive via Yahoo Finance· 4 days agoCurrently, the average analyst estimate has donanemab generating close to $5 billion in annual sales...
Eli Lilly stock hits all-time high: What’s been driving the pharma giant’s share price higher?
Bankrate via AOL· 3 days agoHowever, investors should remain cautious. The full impact of donanemab on the Alzheimer’s treatment...
Doctors couldn’t help. They turned to a shadow system of DIY medical tests.
Anchorage Daily News· 5 days agoHalf a dozen pediatric specialists largely dismissed her daughter’s ailments, Sharma said, forcing...
Common low-calorie sweetener linked to heart attack and stroke, study finds
CNN via Yahoo News· 10 hours agoA common low-calorie sweetener called xylitol, found in gum, candy, toothpaste and more, may cause...
Syntis Bio launches oral therapies for metabolic diseases
Pharmaceutical Technology via Yahoo Finance· 3 days agoThe company's lead obesity programme, SYNT-101, is currently undergoing human...other rare disease...